E-mailbericht RE: Follow-up webinar on reported thromboembolic events following use of COVID-19 Vaccine AstraZeneca, Friday 26 March 11:00 –12:00

Gepubliceerd op:

27 maart 2021

Documentnummer:

vws-woo-08-1233253